glp 1 c elegans Frontiers Mutant C. elegans p53 Together

In addition to diabetes and obesity, GLP-1

While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments

Adults with type 2 diabetes and cancer who used a GLP-1 had a lower risk for death and hospitalization compared with adults who used metformin, according to findings published in The Journal of Clinical Endocrinology &amp

Our 2026 Virta Vitals report just dropped, and it turns out nearly 70% of current and former users prefer to keep it to themselves